Koniku Inc., founded in 2015, is a pioneering player in the convergence of biology and technology with its slogan "Bio is Tech™". The company sees biological neurons as *materials* for use in real-life products and devices, presenting a unique set of solvable technology challenges and vast opportunities. From neurotech to brain-machine interfaces, Koniku is at the forefront, aiming to harness the "raw" biological basis of intelligence. With headquarters in the United States, the company secured a noteworthy $37.00M Series A investment on 17 December 2021, with key investors including Airbus Ventures, IDO Investments, Presight Capital, SoftBank Vision Fund, and Platform Capital. Koniku's positioning at the intersection of biotechnology, health and wellness, IoT, life sciences, and machine learning strengthens its appeal in the rapidly evolving tech landscape.
